Home | Welcome to Contract Pharma   
Last Updated Sunday, July 13 2014
Print

Search Results for 'biotech'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published April 16, 2013
Will initially develop and commercialize six products Read More »
Bio-CMO Industry Trends
By William Downey and Jennifer Hartigan, HighTech Business Decisions
Published April 3, 2013
The market continues its upswing Read More »
Published August 14, 2012
Produces Phase I material Read More »
By Gil Roth
Published June 5, 2012
ADC project in collaboration with MD Anderson Cancer Center Read More »
Published May 21, 2012
Girindus to develop oligonucleotide reagents Read More »
Published May 8, 2012
Marina to provide delivery and chemistry services Read More »
Published April 30, 2012
Program enters lead optimization phase Read More »
Published April 9, 2012
Will be responsible for development and commercialization Read More »
Published February 8, 2010
Teva Pharmaceutical Industries, Ltd. and Active Biotech have amended their marketing and distribution agreement for oral laquinimod, an investigational drug for relapsing-remitting multiple sclerosis (RRMS). Read More »
By Gil Roth
Published April 1, 2009
With bio-financing tight, can service providers find new models? Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On